Vimarsana
Biggest News Aggregation in the World

Page 4 - Nigel Yip News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nigel Yip. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nigel Yip Today - Breaking & Trending Today

Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Cosmetology Treatment - Vimarsana News

Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Cosmetology Treatment

Published: May 30, 2022

/PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi...

Source: prnewswire.com
Related Topics:
United StatesNigel YipBunny LeeAlexis FeinbergMichael MolyneauxPatrick LuDrug AdministrationCompany Or SirnaomicsView ResearchSirnaomics LtdChinese National Medical Products AdministrationFinancial OfficePrnewswire Sirnaomics LtdGrand View ResearchSirnaomics Executive DirectorExecutive DirectorOrphan Drug DesignationChief Medical OfficerMedia ContactSirnaomics LtdHealth Care Amp Hospitals Medical Pharmaceuticals Pharmaceuticals Clinical Trials Amp Medical DiscoveriesNew Products Amp Services
Sirnaomics will present clinical study results and development strategy for Cancer RNA Therapeutics at the 2022 Pre-ASCO China Summit - Vimarsana News

Sirnaomics will present clinical study results and development strategy for Cancer RNA Therapeutics at the 2022 Pre-ASCO China Summit

Published: May 20, 2022

/PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi...

Source: prnewswire.com
Related Topics:
United StatesNew BrunswickNigel YipBunny LeeAlexis FeinbergMichael MolyneauxPatrick LuRegulatory AffairsDalhousie UniversityCompany Or SirnaomicsAmerican Society Of Clinical Oncology China SummitSirnaomics LtdCanadian College Of Family PhysiciansExecutive DirectorChief Medical OfficerAmerican SocietyClinical OncologyChina SummitSkin CancersRegulatory StrategyBeijing TimeZoom WebinarMedical AffairsClinical OperationsMedical Doctorate
Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and GalAhead™ Programs at the TIDES USA 2022 - Vimarsana News

Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and GalAhead™ Programs at the TIDES USA 2022

Published: May 11, 2022

/PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics,...

Source: prnewswire.com
Related Topics:
United StatesHynes Convention CenterNigel YipDmitry SamarskyBunny LeeAlexis FeinbergSirnaomics LtdTriggers ComposedOligonucleotide DiscoverySirnaomics Chief TechnologySirnaomics Chief Technology OfficerFinancial OfficerSirnaomics Ltd
Sirnaomics Doses First Subject in Phase I Clinical Trial of STP707 for the Treatment of Liver Fibrosis in Primary Sclerosing Cholangitis - Vimarsana News

Sirnaomics Doses First Subject in Phase I Clinical Trial of STP707 for the Treatment of Liver Fibrosis in Primary Sclerosing Cholangitis

Published: April 4, 2022

/PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics," stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics,...

Source: prnewswire.com
Related Topics:
United StatesNigel YipMark CorbaeBunny LeeMichael MolyneauxPatrick LuLysine CoSirnaomics LtdPrnewswire Sirnaomics LtdSirnaomics Executive DirectorExecutive DirectorHistidine Lysine Co PolymerChief Medical OfficerFinancial OfficerMedia ContactSirnaomics Ltd
RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines - Vimarsana News

RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines

Published: March 30, 2022

/PRNewswire/ -- RNAimmune, Inc. (the "Company" or "RNAimmune"), a biopharmaceutical company specializing in discovery and development of mRNA-based...

Source: prnewswire.com
Related Topics:
United StatesDong ShenRepublic Of SeychellesNigel YipLos AngelesBunny LeeAlexis FeinbergPatrick LuRnaimmune IncUniversity Of CaliforniaDrug AdministrationSirnaomics LtdRiver Limited SmoothBoulder FundUniversity Of HoustonSmooth River LimitedRotating BoulderExecutive DirectorChief Executive OfficerSeries SeedRotating Boulder FundPolypeptide Lipid NanoparticleMedia ContactSirnaomics Ltd